Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03264092 · ClinicalTrials.gov registry record · NA
Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.
A NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Terminated
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03264092: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.
NCT03264092 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03264092, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.
- TERMINATED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The study's aim is to prospectively compare three different tissue acquisition techniques during EUS guided solid lesions biopsies.
Primary Outcome
0: inadequate 1. limited cytological dx 2. adquate cytological dx 3. limited histological dx 4. adequate histological dx with low quality 5. adequate histological dx with high quality
Interventions
- PROCEDURE Endoscopic ultrasound guided fine needle biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
Why NCT03264092 stopped before completion
NCT03264092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Endoscopic ultrasound guided fine needle biopsy is the first listed.
NCT03264092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03264092 about?
NCT03264092 is a clinical study titled "Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.". The study's aim is to prospectively compare three different tissue acquisition techniques during EUS guided solid lesions biopsies.
What is the current status of trial NCT03264092?
This trial is currently terminated. It is a NA study. The enrollment target is 55 participants. The study started on 2017-09-11. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT03264092?
The interventions under investigation include: Endoscopic ultrasound guided fine needle biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03264092?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03264092's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI